Skip to main content
. 2016 Apr 1;7(18):26516–26534. doi: 10.18632/oncotarget.8530

Figure 8. MAPK and AKT pathways promote miR-520g-DAPK2-mediated EOC cell proliferation.

Figure 8

(A) Western blot analyses of DAPK2, p-AKT, AKT, p-Erk and Erk in A2780/vector cells and A2780/miR-520g cells transfected with the Lv-DAPK2 or control vectors, respectively. (B) Western blot analyses of DAPK2, p-AKT, AKT, p-Erk and Erk in MCAS/NC cells and MCAS/Anti-miR-520g cells transfected with DAPK2/siRNA or scramble, respectively.